Canadian Journal of Cardiology

Quality of Coronary Care: Reducing Practice Variability

Published:January 18, 2023DOI:
      Ischemic heart disease remains the leading cause of death worldwide. In recent decades, developments in percutaneous coronary intervention (PCI) and the overall care for acute coronary syndrome (ACS) have resulted in improved, albeit still variable, outcomes.
      • Udell J.A.
      • Koh M.
      • Qiu F.
      • et al.
      Outcomes of women and men with acute coronary syndrome treated with and without percutaneous coronary revascularisation.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Canadian Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Udell J.A.
        • Koh M.
        • Qiu F.
        • et al.
        Outcomes of women and men with acute coronary syndrome treated with and without percutaneous coronary revascularisation.
        J Am Heart Assoc. 2017; 6e004319
        • Lewis W.R.
        • Peterson E.D.
        • Cannon C.P.
        • et al.
        An organised approach to improvement in guideline adherence for acute myocardial infarction: results with the Get With The Guidelines quality improvement program.
        Arch Intern Med. 2008; 168: 1813-1819
        • Null N.
        • Bradley S.M.
        • Adusumalli S.
        • et al.
        The Cardiovascular Quality Improvement and Care Innovation Consortium.
        Circ Cardiovasc Qual Outcomes. 2021; 14e006753
        • Fox K.A.A.
        • Steg P.G.
        • Eagle K.A.
        • et al.
        Decline in rates of death and heart failure in acute coronary syndromes 1999-2006.
        JAMA. 2007; 297: 1892-1900
        • Kanaoka K.
        • Iwanaga Y.
        • Nakai M.
        • et al.
        Hospital- and patient-level analysis of quality indicators in acute coronary syndrome care: a nationwide database study.
        Can J Cardiol. 2023; 39 (XXX-XX)
        • Canadian Cardiovascular Society
        CCS data definitions & quality indicators.
        • Kanaoka K.
        • Soeda T.
        • Terasaki S.
        • et al.
        Current status and effect of outpatient cardiac rehabilitation after percutaneous coronary intervention in Japan.
        Circ Rep. 2021; 3: 122-130
        • Brady S.
        • Purdham D.
        • Oh P.
        • Grace S.
        Clinical and sociodemographic correlates of referral for cardiac rehabilitation following cardiac revascularisation in Ontario.
        Heart Lung. 2013; 42: 320-325
        • Martin B.J.
        • Hauer T.
        • Arena R.
        • et al.
        Cardiac rehabilitation attendance and outcomes in coronary artery disease patients.
        Circulation. 2012; 126: 677-687
        • Grace S.L.
        • Parsons T.L.
        • Heise K.
        • Bacon S.L.
        The Canadian Cardiac Rehabilitation Registry: inaugural report on the status of cardiac rehabilitation in Canada.
        Rehabil Res Pract. 2015; 2015: 278979
        • CorHealth Ontario
        Report on adult percutaneous coronary interventions (PCI) in Ontario.
        (October 2011–March 2016. April 2018. Available at:)
        • Makita S.
        • Yasu T.
        • Akashi Y.J.
        • et al.
        JCS/JACR 2021 guideline on rehabilitation in patients with cardiovascular disease.
        Circ J. 2022; 87: 155-235
        • Kanaoka K.
        • Iwanaga Y.
        • Nakai M.
        • et al.
        Outpatient cardiac rehabilitation dose after acute coronary syndrome in a nationwide cohort.
        Heart. 2022; 109: 40-46
        • Huang R.
        • Palmer S.C.
        • Cao Y.
        • et al.
        Cardiac rehabilitation programs for chronic heart disease: a bayesian network meta-analysis.
        Can J Cardiol. 2021; 37: 162-171
        • Goto Y.
        Current state of cardiac rehabilitation in Japan.
        Prog Cardiovasc Dis. 2014; 56: 557-562
        • Tamura Y.
        • Yasu T.
        There are not enough facilities for outpatient cardiac rehabilitation—what is the solution?.
        Circ J. 2022; 86: 2008-2009
        • Grace S.L.
        • Turk-Adawi K.
        • Santiago de Araújo Pio C.
        • Alter D.A.
        Ensuring cardiac rehabilitation access for the majority of those in need: a call to action for Canada.
        Can J Cardiol. 2016; 32: S358-S364
        • Bebb O.
        • Hall M.
        • Fox K.A.A.
        • et al.
        Performance of hospitals according to the ESC ACCA quality indicators and 30-day mortality for acute myocardial infarction: national cohort study using the United Kingdom Myocardial Ischemia National Audit Project (MINAP) register.
        Eur Heart J. 2017; 38: 974-982
        • Hoedemaker N.P.G.
        • Damman P.
        • Ottervanger J.P.
        • et al.
        Trends in optimal medical therapy prescription and mortality after admission for acute coronary syndrome: a 9-year experience in a real-world setting.
        Eur Heart J Cardiovasc Pharmacother. 2018; 4: 102-110
        • Czarnecki A.
        • Prasad T.J.
        • Wang J.
        • et al.
        Adherence to process of care quality indicators after percutaneous coronary intervention in Ontario, Canada: a retrospective observational cohort study.
        Open Heart. 2015; 2e000200
        • Nakagawa S.
        • Kume N.
        Pharmacy practice in japan.
        Can J Hosp Pharm. 2017; 70: 232-242
        • Tran M.
        • Pesah E.
        • Turk-Adawi K.
        • et al.
        Cardiac rehabilitation availability and delivery in Canada: how does it compare with other high-income countries?.
        Can J Cardiol. 2018; 34: S252-S262
        • Law M.R.
        • Cheng L.
        • Kolhatkar A.
        • et al.
        The consequences of patient charges for prescription drugs in Canada: a cross-sectional survey.
        CMAJ Open. 2018; 6: e63-e70

      Linked Article